Kestra Private Wealth Services LLC lessened its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 9.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 20,737 shares of the company’s stock after selling 2,174 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in GE HealthCare Technologies were worth $1,621,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. LGT Financial Advisors LLC lifted its stake in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after acquiring an additional 251 shares during the last quarter. Capital Performance Advisors LLP purchased a new stake in GE HealthCare Technologies during the third quarter worth approximately $26,000. Ashton Thomas Securities LLC acquired a new position in GE HealthCare Technologies in the third quarter valued at approximately $26,000. Darwin Wealth Management LLC purchased a new position in GE HealthCare Technologies in the third quarter valued at approximately $31,000. Finally, Continuum Advisory LLC raised its stake in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after acquiring an additional 168 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.
GE HealthCare Technologies Trading Down 1.3 %
Shares of GEHC opened at $85.90 on Thursday. The stock has a market cap of $39.25 billion, a PE ratio of 23.60, a P/E/G ratio of 2.93 and a beta of 1.15. The stock’s 50-day moving average is $83.58 and its two-hundred day moving average is $85.39. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.55. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.
GE HealthCare Technologies Increases Dividend
Wall Street Analyst Weigh In
A number of brokerages have weighed in on GEHC. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and an average price target of $96.77.
Get Our Latest Research Report on GEHC
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Articles
- Five stocks we like better than GE HealthCare Technologies
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Inflation Persists, But So Do Stock Opportunities: Rally On
- What Do S&P 500 Stocks Tell Investors About the Market?
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.